Evidence map›Paper›PMID 40137046›Full record

ReviewMembranes2025

Fouling of Reverse Osmosis (RO) and Nanofiltration (NF) Membranes by Low Molecular Weight Organic Compounds (LMWOCs), Part 2: Countermeasures and Applications.

Yasushi Maeda

Abstract readReview
In one paragraph

Review in Membranes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yasushi MaedaLG Chem Japan Co., Ltd., Kyobashi Trust Tower 12F, 2-1-3 Kyobashi Chuo-ku, Tokyo 104-0031, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fouling, particularly from organic fouling and biofouling, poses a significant challenge in the RO/NF treatment of marginal waters, especially wastewater. Part 1 of this review detailed LMWOC fouling mechanisms. Part 2 focuses on countermeasures and applications. Effective fouling prevention relies on pretreatment, early detection, cleaning, optimized operation, and in situ membrane modification. Accurate fouling prediction is crucial. Preliminary tests using flat-sheet membranes or small-diameter modules are recommended. Currently, no specific fouling index exists for LMWOC fouling. Hydrophobic membranes, such as polyamide, are proposed as alternatives to the standard silt density index (SDI) filter. Once LMWOC fouling potential is assessed, suitable pretreatment methods can be implemented. These include adsorbents, specialized water filters, oxidative decomposition, and antifoulants. In situations where pretreatment is impractical, alternative strategies like high pH operation might be considered. Membrane cleaning becomes necessary upon fouling; however, standard cleaning often fails to fully restore the original flow. Specialized CIP chemicals, including organic solvent-based and oxidative agents, are required. Conversely, LMWOC fouling typically leads to a stabilized flow rate reduction rather than a continuous decline. Aggressive cleaning may be avoided if the resulting operating pressure increase is acceptable. When a significant flow rate drop occurs and LMWOC fouling is suspected, analysis of the fouled membrane is necessary for identification. Standard FT-IR often fails to detect LMWOCs. Solvent extraction followed by GC-MS is required. Pyrolysis GC-MS, which eliminates the extraction step, shows promise. The review concludes by examining how LMWOCs can be strategically utilized to enhance membrane rejection and restore deteriorated membranes.

Indexed as

activated carbonAOPboronbutyl cellosolveCIPcleaningflow lossfoulingGC-MSin situ modificationinternal foulingIPAleachableslog PnanofiltrationNDMAoctanol-water partition coefficientorganic foulingoxidative cleaningozonationPEGphonolicsplasticizaerpore sizepretreatmentrejuvenationreverse osmosisSDIsurfactanttannic acidurea

Identifiers

PMID40137046
PMCPMC11943549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.